Literature DB >> 10442895

Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers.

F E Kruse1, K Rohrschneider, H E Völcker.   

Abstract

PURPOSE: To evaluate the efficacy of multilayer amniotic membrane transplantation for reconstruction of corneal epithelium and stroma in the context of deep corneal ulcers.
DESIGN: Prospective, noncomparative, interventional case series. PARTICIPANTS: Eleven consecutive patients with deep corneal ulcers refractory to conventional treatment; six patients had herpetic keratitis and five had other forms of neurotrophic keratitis. INTERVENTION: Multilayer amniotic membrane transplantation with kryopreserved human amniotic membrane. MAIN OUTCOME MEASURES: Integrity of corneal epithelium and stroma, opacification, and appearance of grafted membrane during 12 months follow-up.
RESULTS: Amniotic membrane transplantation markedly reduced ocular inflammation in all patients. Epithelium healed above all corneal ulcers within 4 weeks and remained stable in 9 of 11 patients for 1 year. Two patients with recurrent epithelial defect suffered from severe neurotrophic keratitis. Following transplantation the amniotic membranes gradually dissolved over a period of 12 months, but stromal thickness remained stable.
CONCLUSION: Amniotic membrane transplantation allows corneal surface reconstruction in patients with persistent epithelial defects. The multilayer technique is useful for treating deep corneal ulcers and even descemetoceles. Because the procedure results in stability of the ocular surface over a period of more than 12 months in most patients, it may be considered an alternative to conventional surgical techniques for ocular surface reconstruction.

Entities:  

Mesh:

Year:  1999        PMID: 10442895     DOI: 10.1016/S0161-6420(99)90444-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  54 in total

1.  Amniotic membrane transplantation for severe neurotrophic corneal ulcers.

Authors:  H J Chen; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  D F Anderson; P Ellies; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

Review 3.  The many possible roles of stem cells in age-related macular degeneration.

Authors:  Sergio Caballero; Nilanjana Sengupta; Sven Crafoord; Raymond Lund; Friedrich E Kruse; Michael Young; Maria B Grant
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

4.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

5.  Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing.

Authors:  Ute Schulze; Ulrike Hampel; Saadettin Sel; Tamme W Goecke; Volker Thäle; Fabian Garreis; Friedrich Paulsen
Journal:  Histochem Cell Biol       Date:  2012-04-03       Impact factor: 4.304

Review 6.  [Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects].

Authors:  B Seitz
Journal:  Ophthalmologe       Date:  2007-12       Impact factor: 1.059

7.  Amniotic membrane-covered bio-onlays for treatment of ocular surface disease.

Authors:  C Cursiefen; C Rummelt; M W Beckmann; F E Kruse
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

8.  Severe methicillin-resistant Staphylococcus aureus infection after multilayer amniotic membrane transplantation.

Authors:  Yuichi Hori; Ryo Inoue; Yasushi Ikuno; Tomoyuki Inoue; Naoyuki Maeda; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

9.  Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels.

Authors:  Nerea Garagorri; Sara Fermanian; Richard Thibault; Winnette McIntosh Ambrose; Oliver D Schein; Shukti Chakravarti; Jennifer Elisseeff
Journal:  Acta Biomater       Date:  2008-05-27       Impact factor: 8.947

Review 10.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.